All In Biotech

Drug Trial Radar · NCT07115004

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)

Last checked: Nov 19, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Oct 15, 2025

Primary completion

Oct 2028

Study completion Oct 2028

Sponsor

Lead sponsor
Vega Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Aug 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)

Conditions

  • Von Willebrand Disease (VWD)

Interventions

  • VGA039Drug

    VGA039 SC administered for 49-weeks during the interventional phase following a 24-week observational period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of bleeding events [Efficacy]Time frame: Time Frame: From 7 days after informed consent until 49 weeks after SC study drug initiation

Locations

32 sites in 10 countries. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital

    Little Rock, Arkansas · Recruiting

  • Luskin Orthopaedic Institute For Children

    Los Angeles, California · Recruiting

  • Stanford University

    Palo Alto, California · Recruiting

  • UC Davis Medical Center

    Sacramento, California · Recruiting

  • University of California San Francisco

    San Francisco, California · Recruiting

  • Yale University School of Medicine

    New Haven, Connecticut · Recruiting

  • Emory University Hospital

    Atlanta, Georgia · Recruiting

  • Children's Healthcare of Atlanta

    Atlanta, Georgia · Recruiting

  • University of Michigan Health

    Ann Arbor, Michigan · Recruiting

  • University of Minnesota

    Minneapolis, Minnesota · Recruiting

  • Science 37, Inc. (Virtual Clinical MetaSite)

    Morrisville, North Carolina · Recruiting

  • Hemophilia Center of Western PA

    Pittsburgh, Pennsylvania · Recruiting

  • UT Southwestern Children's Hospital

    Dallas, Texas · Recruiting

  • Washington Center for Bleeding Disorders

    Seattle, Washington · Recruiting

  • Royal Prince Alfred Hospital, Institute of Haematology

    Sydney, New South Wales (nsw), Australia · Recruiting

  • Royal Brisbane & Women's Hospital (RBWH), Queensland Haemophilia Centre

    Brisbane, Queensland, Australia · Recruiting

  • The Alfred Hospital (Alfred Health),Monash University

    Melbourne, Victoria, Australia · Recruiting

  • Medical University of Vienna

    Vienna, Austria · Recruiting

  • Multihemo - Oncoclínicas

    Recife, Pernambuco, Brazil · Recruiting

  • Centro de Hemoterapia e Hematologia do Rio de Janeiro (HEMORIO)

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

  • emocentro UNICAMP (Centro de Hematologia e Hemoterapia da UNICAMP), University of Campinas (UNICAMP)

    Campinas, São Paulo, Brazil · Recruiting

  • Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP)

    São Paulo, São Paulo, Brazil · Recruiting

  • K Eristavi National Center of Experimental and Clinical Surgery (ქირურგიის ეროვნული ცენტრი)

    Tbilisi, Georgia · Recruiting

  • Vivantes Klinikum im Friedrichshain

    Berlin, Germany · Recruiting

  • Frankfurt University Hospital (Universitätsmedizin Frankfurt)

    Frankfurt, Germany · Recruiting

  • St. James's Hospital, National Coagulation Centre

    Dublin, Dublin, Ireland · Recruiting

  • Azienda Ospedaliero-Universitaria Careggi (Careggi University Hospital)

    Florence, Italy · Recruiting

  • University of Milan

    Milan, Milan, Italy · Recruiting

  • Charlotte Maxeke Johannesburg Academic Hospital School of Pathology Clinical Haematologist

    Johannesburg, South Africa · Recruiting

  • Worthwhile Clinical Trials Lakeview Hospital

    Benoni, Gauteng, South Africa · Recruiting

  • Imperial College Healthcare NHS Trust, Hammersmith Hospital

    London, Greater London, United Kingdom · Recruiting

  • Royal Free London NHS Foundation Trust,

    London, London, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.